FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Pharyngoesophageal junction cancer is not a good candidate for endoscopically assisted transoral surgery.

2.

A Century of Schizophrenia: One Disorder or Many?

3.

Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?

4.

Photopenia on [18F]FDG PET/CT Predicts Benign Renal Lesions

5.

Significant worldwide disparities seen in availability and timeliness of new cancer drugs


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot